Materna Medical Presents Interim Data Advancing Understanding of Dilation Therapy on Vaginismus and Related Painful Sex at NPWH Annual Meeting
Abstract reveals promising 3-month data from an at-home clinical trial, offering nurse practitioners and women’s health providers a new perspective on sexual health
October 1, 2025 [Mountain View, Calif.]—Materna Medical announced today that interim 3-month results from its Prospective On Market Patient-reported Outcomes for Milli (POMPOM) clinical study will be presented at the Nurse Practitioners in Women’s Health (NPWH) Annual Conference.
The abstract, titled “POMPOM 3-Month Interim Report Measuring Effectiveness on Vaginismus and Dyspareunia Using a Novel Expanding Dilator,” highlights statistically significant improvements in pain, sexual function, and anxiety among participants using the Milli vaginal dilator over three months.
These initial findings are valuable, real-world insight for nurse practitioners at the forefront of providing comprehensive care to women.
The data highlight the substantial impact of this condition on a patient’s life and suggest a potential new first-line therapeutic option that can alleviate symptoms and enhance quality of life.
When asked to describe any impact that Milli has had on their sex life, one study participant reported, “Using Milli has greatly improved my sex life. I no longer have to worry about it being painful.”
